NKMAX 的蛋白质和抗体开发源于其稳定肽 (SP) 融合技术，该技术最初旨在稳定易受环境损害的蛋白质。
NKMAX 生产超过 5,000 种不同的重组蛋白和超过 400 种单克隆抗体，在全球超过 38 个国家销售。
nkmaxbio2021年9月新增蛋白产品：
|
Product Name |
Catalog# |
Size |
Size |
Size |
|
|
Signal Transduction, Cytoskeleton |
Recombinant human COMP protein |
ATGP4037 |
500ug |
100ug |
50ug |
|
Angiogenesis, Cardiovascular |
Recombinant human EphB1 protein |
ATGP4038 |
500ug |
100ug |
50ug |
|
Immunology |
Recombinant human IL-17RB protein |
ATGP4039 |
500ug |
100ug |
50ug |
|
Angiogenesis, Cardiovascular, Adhesion & Movement |
Recombinant mouse TIMP-1 protein |
ATGP4040 |
500ug |
100ug |
50ug |
|
Cell Cycle |
Recombinant human MKK6 protein |
ATGP4041 |
500ug |
100ug |
50ug |
|
Immunology |
Recombinant human LILRB2/CD85d/ILT4 protein |
ATGP4042 |
500ug |
100ug |
50ug |